Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -30.00 (-2.38%)
Bid:
1,232.00
Ask:
1,246.00
Spread: 14.00 (1.136%)
Market Cap: £239.12m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Holding(s) in Company

9 Dec 2024 10:55

The Biotech Growth Trust PLC - Holding(s) in Company

The Biotech Growth Trust PLC - Holding(s) in Company

PR Newswire

LONDON, United Kingdom, December 09

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0000385517

Issuer Name

THE BIOTECH GROWTH TRUST PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Border to Coast Pensions Partnership Ltd

City of registered office (if applicable)

Leeds

Country of registered office (if applicable)

UK

4. Details of the shareholder

Name

City of registered office

Country of registered office

Northern Trust Global Services SE

 

 

5. Date on which the threshold was crossed or reached

06-Dec-2024

6. Date on which Issuer notified

06-Dec-2024

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.110000

0.000000

4.110000

1284902

Position of previous notification (if applicable)

5.008816

0.000000

5.008816

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0000385517

 

1284902

 

4.110000

Sub Total 8.A

1284902

4.110000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Teodora Harrop Head of Compliance 0113 487 2475

12. Date of Completion

09-Dec-2024

13. Place Of Completion

Floor 5, Toronto Square, Toronto Street, Leeds, LS1 2HJ



Date   Source Headline
3rd Jun 20263:56 pmPRNNet Asset Value(s)
3rd Jun 20267:00 amPRNAnnual Financial Report
2nd Jun 202612:32 pmPRNNet Asset Value(s)
1st Jun 20263:04 pmPRNNet Asset Value(s)
1st Jun 202611:12 amPRNTotal Voting Rights
29th May 20265:22 pmPRNTransaction in Own Shares
29th May 20261:56 pmPRNNet Asset Value(s)
28th May 202612:52 pmPRNNet Asset Value(s)
27th May 20261:40 pmPRNNet Asset Value(s)
26th May 20261:15 pmPRNNet Asset Value(s)
22nd May 20265:19 pmPRNTransaction in Own Shares
22nd May 20261:30 pmPRNNet Asset Value(s)
21st May 20261:47 pmPRNNet Asset Value(s)
20th May 20261:07 pmPRNNet Asset Value(s)
19th May 20263:56 pmPRNNet Asset Value(s)
18th May 20262:33 pmPRNNet Asset Value(s)
15th May 20265:30 pmPRNTransaction in Own Shares
15th May 20263:00 pmPRNNet Asset Value(s)
14th May 20265:16 pmPRNMonthly Fact Sheet as at 30 April 2026
14th May 20261:02 pmPRNNet Asset Value(s)
13th May 20262:46 pmPRNNet Asset Value(s)
12th May 20261:02 pmPRNNet Asset Value(s)
11th May 20261:33 pmPRNNet Asset Value(s)
8th May 20265:21 pmPRNTransaction in Own Shares
8th May 20261:56 pmPRNNet Asset Value(s)
7th May 202612:58 pmPRNNet Asset Value(s)
6th May 20262:09 pmPRNNet Asset Value(s)
5th May 20261:49 pmPRNNet Asset Value(s)
1st May 20265:32 pmPRNCompliance with Market Abuse Regulation
1st May 20265:20 pmPRNTransaction in Own Shares
1st May 20262:47 pmPRNARCHIMED to acquire BIOG portfolio company, Esperion Therapeutics.
1st May 20261:37 pmPRNNet Asset Value(s)
1st May 20269:48 amPRNTotal Voting Rights
30th Apr 20261:16 pmPRNNet Asset Value(s)
29th Apr 20262:31 pmPRNNet Asset Value(s)
28th Apr 20261:12 pmPRNNet Asset Value(s)
27th Apr 20261:08 pmPRNNet Asset Value(s)
24th Apr 20265:40 pmPRNTransaction in Own Shares
24th Apr 20261:51 pmPRNNet Asset Value(s)
23rd Apr 20261:10 pmPRNNet Asset Value(s)
22nd Apr 20263:05 pmPRNNet Asset Value(s)
21st Apr 202611:45 amPRNNet Asset Value(s)
20th Apr 20262:28 pmPRNNet Asset Value(s)
17th Apr 20265:23 pmPRNTransaction in Own Shares
17th Apr 20262:38 pmPRNNet Asset Value(s)
16th Apr 20261:21 pmPRNNet Asset Value(s)
15th Apr 202612:59 pmPRNNet Asset Value(s)
14th Apr 202612:46 pmPRNNet Asset Value(s)
13th Apr 20261:44 pmPRNNet Asset Value(s)
13th Apr 202610:31 amPRNMonthly Fact Sheet as at 31 March 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.